Eli Lilly (LLY 0.40%) and Novo Nordisk (NVO 1.97%) are two phenomenal growth stocks that investors probably can't go wrong ...

Danish pharmaceutical giant Novo Nordisk has announced a new 800-million-yuan (approximately USD 111.9 million) investment to ...

Ever since Frederiksen took office in Denmark in 2019, the second woman and youngest person ever to become prime minister in ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

This month, the Danish prime minister Mette Frederiksen takes up her presidency of the EU – and the timing could not be more ...

Novo Nordisk saw a significant decline as it lost over 55% from its highs in June 2024. Check out the reasons for the decline and my recommendation of NVO stock.

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Officials in Greenland and Denmark insist the world's largest island isn't for sale. Is President Donald Trump hearing them? Does it matter?

Novo’s rise It’s difficult to overstate the recent success of Novo Nordisk, which boasted a turnover of €38.9 billion in 2024 — of which €13.5 billion was profit — and accounts for nearly half of ...

But the active ingredient, semaglutide, is made in Denmark. If Denmark ordered Novo Nordisk to stop supplying the U.S., the supply of the drugs in the U.S. would disappear overnight.

Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the Triangle region's largest employers.

Novo Nordisk manufacturers some of its drugs in the United States, but it still imports the active pharmaceutical ingredient, semaglutide, for some of its most popular injectable drugs.